中药对肥胖相关性肾病患者胰岛素抵抗及血尿酸水平的影响
发布时间：2018-08-12 09:03
【摘要】：目的:探讨中药对肥胖相关性肾病患者胰岛素抵抗及血尿酸水平的影响。方法:选取115例ORG患者分成治疗组及对照组,2组均进行药物、饮食及运动疗法,治疗组加服中药治疗1个月,记录治疗前后各项指标进行统计学分析。结果:总有效率治疗组优于对照组。2组干预1个月后体质量、腰围、体质量指数、血糖、空腹胰岛素、胰岛素抵抗指数及血尿素水平均下降,与治疗前比较差异有统计学意义,治疗组优于对照组。2组血液流变学指标较治疗前均有改善,差异有统计学意义,治疗组优于对照组。结论:ORG患者采用中药治疗可降低胰岛素抵抗指数及血尿酸水平,降低血脂、血压、血糖及体质量。
[Abstract]:Objective: to investigate the effect of traditional Chinese medicine on insulin resistance and serum uric acid level in obese related nephropathy patients. Methods: 115 patients with ORG were divided into two groups: treatment group and control group were treated with drugs, diet and exercise therapy. The treatment group was treated with Chinese medicine for one month, and the indexes before and after treatment were recorded and analyzed statistically. Results: the total effective rate in the treatment group was better than that in the control group after one month of intervention. The body mass, waist circumference, body mass index, blood glucose, fasting insulin, insulin resistance index and blood urea level were significantly lower in the treatment group than in the control group. The hemorheology index of the treatment group was better than that of the control group, the difference was statistically significant, and the treatment group was better than the control group. Conclusion the treatment with Chinese medicine can reduce insulin resistance index and serum uric acid level, reduce blood lipids, blood pressure, blood glucose and body mass.
【作者单位】： 迁安市人民医院;玉田县医院;中日友好医院;
【基金】：河北省科技厅计划支撑项目(12277789)-中西医结合治疗肥胖相关性肾病的临床研究(申请专利号201510160620.6)
【分类号】：R259;R277.5
本文编号：2178584
[Abstract]:Objective: to investigate the effect of traditional Chinese medicine on insulin resistance and serum uric acid level in obese related nephropathy patients. Methods: 115 patients with ORG were divided into two groups: treatment group and control group were treated with drugs, diet and exercise therapy. The treatment group was treated with Chinese medicine for one month, and the indexes before and after treatment were recorded and analyzed statistically. Results: the total effective rate in the treatment group was better than that in the control group after one month of intervention. The body mass, waist circumference, body mass index, blood glucose, fasting insulin, insulin resistance index and blood urea level were significantly lower in the treatment group than in the control group. The hemorheology index of the treatment group was better than that of the control group, the difference was statistically significant, and the treatment group was better than the control group. Conclusion the treatment with Chinese medicine can reduce insulin resistance index and serum uric acid level, reduce blood lipids, blood pressure, blood glucose and body mass.
【作者单位】： 迁安市人民医院;玉田县医院;中日友好医院;
【基金】：河北省科技厅计划支撑项目(12277789)-中西医结合治疗肥胖相关性肾病的临床研究(申请专利号201510160620.6)
【分类号】：R259;R277.5
【相似文献】
相关期刊论文 前5条
1 刘成福;王小琴;范为民;黄飞;;从脾肾论治肥胖相关性肾病[J];中西医结合研究;2012年05期
2 邹昀;董志刚;;肥胖相关性肾病从痰、虚论治探析[J];光明中医;2014年05期
3 于敏;王姣;刘容锐;熊锡山;文娜;刘晓玲;;肥胖相关性肾病的发病机制与中医“痰浊致病”的相关性探讨[J];中华中医药学刊;2010年06期
4 卞鲁岩;;黄葵胶囊对肥胖相关性肾病患者胰岛素抵抗的影响[J];中国中西医结合肾病杂志;2010年12期
5 ;[J];;年期
相关硕士学位论文 前3条
1 张浩;从脾肾为本痰湿为标辨治肥胖相关性肾病的临床研究[D];黑龙江中医药大学;2008年
2 安安;温胆降脂颗粒治疗肥胖相关性肾病的临床观察[D];山东中医药大学;2014年
3 杨婉蓉;荷夏化浊颗粒对肥胖相关性肾病的干预治疗及对脂联素水平的影响[D];山东中医药大学;2015年
，本文编号：2178584
本文链接：https://www.wllwen.com/zhongyixuelunwen/2178584.html
最近更新
教材专著
